Welcome to our dedicated page for NH news (Ticker: NH), a resource for investors and traders seeking the latest updates and insights on NH stock.
NantHealth (NH) delivers innovative healthcare solutions through its unique integration of advanced diagnostics and comprehensive data analytics. This dedicated news hub provides investors and healthcare professionals with essential updates on the company's progress in precision medicine.
Access timely reports on clinical developments, technology partnerships, and operational milestones that shape NH's position in healthcare innovation. Our curated collection includes earnings announcements, regulatory filings, product launch details, and strategic collaborations within the medical technology sector.
Key areas of coverage feature NH's systems-based approach to treatment optimization, advancements in biometric data integration, and initiatives supporting value-based care models. Stay informed about developments impacting personalized healthcare delivery and diagnostic technology evolution.
Bookmark this page for streamlined access to verified NH updates. Check regularly for new insights into how the company continues bridging healthcare services with actionable data solutions.
NantHealth (NH) has expanded its NaviNet AllPayer service with new claim submission functionality, allowing healthcare providers to electronically submit and track claims for over 8,100 organizations. The platform now offers four subscription tiers: Standard, Basic, Premium, and Ultimate, each with varying levels of access to health plan workflows, patient lists, and drug authorizations.
The enhanced service includes access to eligibility and benefits information for more than 1,270 plans and claim status inquiry for over 660 commercial plans. According to Scott Maratea, NantHealth Chief Revenue Officer, the platform currently processes over 200,000 transactions monthly. The system streamlines administrative workflows by eliminating the need for multiple portal logins and enables real-time data exchange with health plans nationwide.
NantHealth (NASDAQ-GS: NH) has appointed Scott Maratea as its new Chief Revenue Officer. With over 30 years of experience in healthcare technology, Maratea has a proven track record of exceeding revenue targets and growing client relationships with leading healthcare organizations. Previously, he served as CRO at Curve Health and Life Image, Inc., demonstrating success in sales, marketing, and business development.
In his new role, Maratea will lead NantHealth's sales and revenue generation efforts, focusing on driving growth and expanding the company's market presence. His appointment is expected to help NantHealth achieve its growth objectives and continue delivering innovative healthcare solutions.
NantHealth (NASDAQ: NH) has received a 3-year reaccreditation for its Utilization Management Program from the National Committee for Quality Assurance (NCQA). This accreditation underscores the program's high standards in consumer protection and service improvement. NCQA accreditation, known for its rigorous and comprehensive standards, signifies excellence in healthcare quality and accountability. Haris Naseem, CEO of NantHealth, and Megan Salmon-Gardell, Chief Nursing Officer, emphasized that this achievement reaffirms NantHealth's commitment to superior healthcare delivery and patient outcomes.
NantHealth, Inc. (NASDAQ: NH) has achieved HITRUST Risk-based, 2-year Certified status for its Eviti Connect solution, confirming its adherence to crucial regulations and security standards.
This certification places NantHealth among a select group of organizations globally, showcasing its commitment to data protection and information security. The HITRUST Assurance Program offers comprehensive controls addressing security and data challenges, which is essential in today’s evolving threat landscape.
Ron Louks, COO of NantHealth, emphasizes their dedication to maintaining the highest data protection standards through this achievement.
NantHealth, Inc. (NASDAQ: NH) has entered into a credit agreement for a new senior secured term loan totaling $22.5 million. The funding aims to support the company's ongoing operations and general corporate needs. Investors Highbridge Capital Management and Nant Capital are providing the loan. CEO Dr. Patrick Soon-Shiong highlighted the role of artificial intelligence in transforming healthcare, while COO Ron Louks emphasized the investment's potential to enhance established solutions like NaviNet and Eviti. The company's board has unanimously endorsed the transaction.
The OpenNMS Group, a subsidiary of NantHealth (NASDAQ: NH), has announced the release of OpenNMS Meridian 2023, enhancing its network monitoring solutions. This release focuses on cloud services and containerization benefits. Key features include a scalable time series database, containerized deployment, flow thresholding for anomaly detection, native device configuration backups, and a new hardware appliance to streamline operations. OpenNMS emphasizes security with initiatives like zero-trust architecture and alignment with ISO 27001. Meridian is available as a subscription service, ensuring users have access to stable and secure monitoring capabilities.
NantHealth (NASDAQ: NH) has announced a reverse stock split of 1-for-15, effective December 15, 2022, at 5 p.m. ET. This action, approved by stockholders on August 18, 2022, aims to increase the trading price of its common stock to meet Nasdaq's minimum bid requirement. The total shares will decrease from approximately 115.5 million to about 7.7 million, while the authorized shares remain at 750 million. No fractional shares will be issued; instead, stockholders will receive cash for any fractions. The stock continues to trade under the symbol 'NH.'
NantHealth, Inc. (NH) reported Q3 2022 net revenue of $16.6 million, a 15% increase from $14.4 million in Q3 2021, marking the fourth consecutive quarter of revenue growth.
The gross profit reached $9.7 million (58% margin), the highest since Q4 2020. However, net loss increased to $13.7 million ($0.12 per share) compared to $10.8 million ($0.09 per share) in the prior year.
The company secured multiple contract renewals and extended relationships, including a three-year agreement with a national insurer covering over two million Medicaid members.
